| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.945863 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20250313081456 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 241204e202502##onca obs f000 0 eng d |
|---|
| 020 | |a9780660747705 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 045 | |ay1y2 |
|---|
| 086 | 1 |aH82-55/2025E-PDF |
|---|
| 245 | 00|aPrivate drug plans in Canada : |bexpenditure report, 2018-2023. |
|---|
| 264 | 1|aOttawa, ON : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |cFebruary 2025. |
|---|
| 264 | 4|c©2025 |
|---|
| 300 | |a1 online resource (vi pages, 1 unnumbered page, 41 pages) : |bcolour illustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Régimes privés d'assurance-médicaments au Canada : rapport sur les dépenses, 2018-2023. |
|---|
| 500 | |aOn cover: NPDUIS, National Prescription Drug Utilization Information System. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"This report provides a comprehensive analysis of trends in prescription drug expenditures from the perspective of Canadian private drug plans. From 2018 to 2023, private pay-direct drug plans experienced a compound annual growth rate of 7.1%, with a significant 12.9% increase in 2023. This growth in 2023 was uneven across its two main components: drug costs (which saw an increase of 14.1%) and dispensing costs (which saw an increase of 4.5%). Over past years, rising expenditures in private plans were consistently driven primarily by significant increases in the use of newer and higher-cost drugs. A comparative analysis with Canadian public drug plans is also included in the report. …"--Executive summary, page iv. |
|---|
| 650 | 0|aPharmaceutical services insurance|zCanada|xCosts|vStatistics. |
|---|
| 650 | 0|aPrescription pricing|zCanada|vStatistics. |
|---|
| 655 | 7|aStatistics|2lcgft |
|---|
| 710 | 1 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body. |
|---|
| 775 | 08|tRégimes privés d'assurance-médicaments au Canada : |w(CaOODSP)9.945864 |
|---|
| 856 | 40|qPDF|s988 KB|uhttps://publications.gc.ca/collections/collection_2025/cepmb-pmprb/H82-55-2025-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/private-drug-plans-2018-2023.html |
|---|